At the request of Sage Publishing and the Journal Editor, the following article has been retracted:
Li G, Huang X. Influence of sodium ferulate on miR-133a and left ventricle remodeling in rats with myocardial infarction. Human & Experimental Toxicology. 2021;40(3):417-424. doi:10.1177/0960327120950006
Sage Publishing was made aware that this article may have been submitted with third-party involvement. We did not receive a response from the authors when we attempted to contact them for comment.
This article has been retracted due to our unresolved concerns on the authenticity of the authorship.
The authors did not respond when notified of this retraction.
References
1.
BonacaMPBhattDLCohenM, et al.Long-term use of ticagrelor in patients with prior myocardial infarction. N Engl J Med2015; 372: 1791–1800.
2.
HofmannRJamesSKJernbergT, et al.Oxygen therapy in suspected acute myocardial infarction. N Engl J Med2017; 377: 1240–1249.
3.
CungT-TMorelOCaylaG, et al.Cyclosporine before PCI in patients with acute myocardial infarction. N Engl J Med2015; 373: 1021–1031.
4.
ZhengQHuangY-YZhuP-C, et al.Ligustrazine exerts cardioprotection in animal models of myocardial ischemia/reperfusion injury: preclinical evidence and possible mechanisms. Front Pharmacol2018; 9: 729.
5.
QinJShangLPingA-S, et al.TNF/TNFR signal transduction pathway-mediated anti-apoptosis and anti-inflammatory effects of sodium ferulate on IL-1β-induced rat osteoarthritis chondrocytes in vitro. Arthritis Res Ther2012; 14: R242.
6.
TianLDangX-QWangC-S, et al.Effects of sodium ferulate on preventing steroid-induced femoral head osteonecrosis in rabbits. J Zhejiang Univ Sci B2013; 14: 426–437.
7.
WangBHOu-YangJP. Pharmacological actions of sodium ferulate in cardiovascular system. Cardiovasc Drug Rev2005; 23: 161–172.
8.
JungMMaYIyerRP, et al.IL-10 improves cardiac remodeling after myocardial infarction by stimulating M2 macrophage polarization and fibroblast activation. Basic Res Cardiol2017; 112: 33.
9.
KurianGARajagopalRVedanthamS, et al.The role of oxidative stress in myocardial ischemia and reperfusion injury and remodeling: revisited. Oxid Med Cell Longev2016; 2016: 1656450.
10.
ZhouQGongXKuangG, et al.Ferulic acid protected from kidney ischemia reperfusion injury in mice: possible mechanism through increasing adenosine generation via HIF-1α. Inflammation2018; 41: 2068–2078.
11.
GarciaRVillarAVCoboM, et al.Circulating levels of miR-133a predict the regression potential of left ventricular hypertrophy after valve replacement surgery in patients with aortic stenosis. J Am Heart Assoc2013; 2: e000211.
12.
LiQLinXYangX, et al.NFATc4 is negatively regulated in miR-133a-mediated cardiomyocyte hypertrophic repression. Am J Physiol Heart Circ Physiol2010; 298: H1340–H1347.
13.
LeeS-YLeeCYHamO, et al.microRNA-133a attenuates cardiomyocyte hypertrophy by targeting PKCδ and Gq. Mol Cell Biochem2018; 439: 105–115.
14.
WolfensohnSLloydM. Handbook of laboratory animal management and welfare. Hoboken, NJ: John Wiley & Sons, 2008.
15.
YangMLiBLiuJ, et al.Protection effect of survivin protein overexpression on acute myocardial infarction in rats. Int J Clin Exp Med2015; 8: 12995.
16.
TabuchiMNegishiJYamashitaA, et al.Effect of decellularized tissue powders on a rat model of acute myocardial infarction. Mater Sci Eng C Mater Biol Appl2015; 56: 494–500.
17.
HuBSongJTJiXF, et al.Sodium ferulate protects against angiotensin ii-induced cardiac hypertrophy in mice by regulating the MAPK/ERK and JNK pathways. Biomed Res Int2017; 2017: 3754942.
18.
MalekMNematbakhshM. Renal ischemia/reperfusion injury; from pathophysiology to treatment. J Renal Inj Prev2015; 4: 20.
19.
FerrariRSAndradeCF. Oxidative stress and lung ischemia-reperfusion injury. Oxid Med Cell Longev2015; 2015: 590987.
20.
NimseSBPalD. Free radicals, natural antioxidants, and their reaction mechanisms. RSC Adv2015; 5: 27986–28006.
21.
TsikasD. Assessment of lipid peroxidation by measuring malondialdehyde (MDA) and relatives in biological samples: analytical and biological challenges. Anal Biochem2017; 524: 13–30.
22.
CaoAWangLChenX, et al.Ursodeoxycholic acid ameliorated diabetic nephropathy by attenuating hyperglycemia-mediated oxidative stress. Biol Pharm Bull2016; 39: 1300–1308.
23.
Run-meiXJun-junWJing-yaC, et al.Effects of arecoline on hepatic cytochrome P450 activity and oxidative stress. J Toxicol Sci2014; 39: 609–614.
24.
GaoYHaoJZhangH, et al.Protective effect of the combinations of glycyrrhizic, ferulic and cinnamic acid pretreatment on myocardial ischemia-reperfusion injury in rats. Exp Ther Med2015; 9: 435–445.
25.
Ekinci AkdemirFNGülçinİKaragözB, et al.A comparative study on the antioxidant effects of hesperidin and ellagic acid against skeletal muscle ischemia/reperfusion injury. J Enzyme Inhib Med Chem2016; 31: 114–118.
26.
XuXXiaoHZhaoJ, et al.Cardioprotective effect of sodium ferulate in diabetic rats. Int J Med Sci2012; 9: 291–300.
27.
YoshizumiTZhuYJiangH, et al.Timing effect of intramyocardial hydrogel injection for positively impacting left ventricular remodeling after myocardial infarction. Biomaterials2016; 83: 182–193.
28.
LuoMChenP-pYangL, et al.Sodium ferulate inhibits myocardial hypertrophy induced by abdominal coarctation in rats: Involvement of cardiac PKC and MAPK signaling pathways. Biomed Pharmacother2019; 112: 108735.
29.
FrangogiannisNG. The immune system and cardiac repair. Pharmacol Res2008; 58: 88–111.
30.
SangH-QJiangZ-MZhaoQ-P, et al.MicroRNA-133a improves the cardiac function and fibrosis through inhibiting Akt in heart failure rats. Biomed Pharmacother2015; 71: 185–189.
31.
HuangLXiZWangC, et al.Phenanthrene exposure induces cardiac hypertrophy via reducing miR-133a expression by DNA methylation. Sci Rep2016; 6: 20105.
32.
NandiSSShahshahanHRShangQ, et al.MiR-133a mimic alleviates T1DM-induced systolic dysfunction in Akita: a MRI-based study. Front Physiol2018; 9: 1275.
